Alpha Tau Medical Ltd: A Leader in Radiation Therapy for Solid Tumors

Alpha Tau Medical Ltd, a prominent player in the healthcare sector, is headquartered in Wilmington, Delaware, USA. The company is renowned for its specialization in developing and manufacturing innovative medical devices, particularly focusing on diffusing alpha-emitters radiation therapy. This advanced treatment is designed for the conformal treatment of solid tumors, offering a targeted approach to cancer therapy.

As of August 10, 2025, Alpha Tau Medical’s stock closed at $3.56 on the Nasdaq exchange. The company’s market capitalization stands at approximately $250.55 million. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of $4.387 on January 26, 2025, and a low of $2.07 on August 13, 2024.

Alpha Tau Medical serves a global patient base, providing cutting-edge solutions in radiation therapy. The company’s commitment to innovation and patient care is evident in its product offerings and services. For more detailed information about their products and services, interested parties can visit their website at www.alphatau.com .

The company’s focus on diffusing alpha-emitters radiation therapy positions it as a leader in the field of oncology, offering hope and advanced treatment options to patients worldwide. As Alpha Tau Medical continues to expand its reach and enhance its technological capabilities, it remains a key player in the healthcare sector, dedicated to improving patient outcomes through innovative medical solutions.